Targeting cellular surface markers using principles cancer stem cells have a protein on the cell surface is specific, unlike normal cells around it to design antibodies that are toxic to cells (cytotoxic agents), adhering to handle. This protein Specifications Then the destruction of cancer stem cells, such as CD33, a protein that is specific to the particular expression leukemia without Elo Blas (acute myeloblastic leukemia: AML) currently being developed drug gemtuzumab ozogamicin as antibodies. CD33 human protein that is toxic to cells of the island is calicheamicin. Currently widely used to treat AML 48. There is also a protein, CD47, a protein expressed highly specific myeloid leukemia lymphocytes Blas (acute lymphoblastic leukemia: ALL) brain cancer types glioma is an expression of the protein CD133 high, which is currently being developed by. With the use of carbon nanotubes with an antibody that sticks to the type CD133 monoclonal antibody, followed by irradiation of the near-infrared radiation (infrared laser) which will destroy brain cancer cells that are CD133 + Omar far only 49.
การแปล กรุณารอสักครู่..